CA1286667C - 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives - Google Patents

4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives

Info

Publication number
CA1286667C
CA1286667C CA000531106A CA531106A CA1286667C CA 1286667 C CA1286667 C CA 1286667C CA 000531106 A CA000531106 A CA 000531106A CA 531106 A CA531106 A CA 531106A CA 1286667 C CA1286667 C CA 1286667C
Authority
CA
Canada
Prior art keywords
pyrimidinyl
piperazinyl
alkyl
tetrahydro
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000531106A
Other languages
English (en)
French (fr)
Inventor
Marcel Hibert
Maurice Ward Gittos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of CA1286667C publication Critical patent/CA1286667C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA000531106A 1986-03-05 1987-03-04 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives Expired - Fee Related CA1286667C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83627786A 1986-03-05 1986-03-05
US836,277 1986-03-05

Publications (1)

Publication Number Publication Date
CA1286667C true CA1286667C (en) 1991-07-23

Family

ID=25271609

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000531106A Expired - Fee Related CA1286667C (en) 1986-03-05 1987-03-04 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives

Country Status (18)

Country Link
EP (1) EP0238905B1 (no)
JP (1) JPH0778043B2 (no)
KR (1) KR900000413B1 (no)
CN (1) CN1023484C (no)
AR (2) AR242678A1 (no)
AT (1) ATE93523T1 (no)
AU (1) AU588671B2 (no)
CA (1) CA1286667C (no)
DE (1) DE3787109T2 (no)
DK (1) DK111987A (no)
ES (1) ES2059316T3 (no)
FI (1) FI870925A7 (no)
HU (1) HU197567B (no)
NO (1) NO167390C (no)
NZ (1) NZ219456A (no)
PH (1) PH24912A (no)
PT (1) PT84408B (no)
ZA (1) ZA871450B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206109B (en) * 1987-10-26 1992-08-28 Pfizer Process for producing heterocyclic carbonylpropyl pyrimidinyl piperazine derivatives and pharmaceutical compositions comprising same
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
NZ233398A (en) * 1989-04-22 1991-12-23 American Home Prod Aryl- or heteroaryl-substituted piperazine derivatives and pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
DE2727469A1 (de) * 1977-06-18 1978-12-21 Hoechst Ag Neue hexahydropyrimidine, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
HU206109B (en) * 1987-10-26 1992-08-28 Pfizer Process for producing heterocyclic carbonylpropyl pyrimidinyl piperazine derivatives and pharmaceutical compositions comprising same
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives

Also Published As

Publication number Publication date
DK111987D0 (da) 1987-03-04
HU197567B (en) 1989-04-28
FI870925L (fi) 1987-09-06
FI870925A7 (fi) 1987-09-06
DE3787109T2 (de) 1994-02-10
AR242790A1 (es) 1993-05-31
KR900000413B1 (ko) 1990-01-30
PT84408A (en) 1987-04-01
EP0238905B1 (en) 1993-08-25
AR242678A1 (es) 1993-04-30
JPH0778043B2 (ja) 1995-08-23
CN87101688A (zh) 1988-03-02
EP0238905A3 (en) 1989-08-09
NO870891D0 (no) 1987-03-04
AU588671B2 (en) 1989-09-21
NO167390B (no) 1991-07-22
AU6960787A (en) 1987-09-10
DK111987A (da) 1987-09-06
NZ219456A (en) 1989-08-29
PH24912A (en) 1990-12-26
EP0238905A2 (en) 1987-09-30
HUT43591A (en) 1987-11-30
NO167390C (no) 1991-10-30
CN1023484C (zh) 1994-01-12
ZA871450B (en) 1987-08-20
KR870008874A (ko) 1987-10-21
JPS62265285A (ja) 1987-11-18
FI870925A0 (fi) 1987-03-03
PT84408B (pt) 1989-10-04
ES2059316T3 (es) 1994-11-16
NO870891L (no) 1987-09-07
DE3787109D1 (de) 1993-09-30
ATE93523T1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
US4748182A (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
US4818756A (en) 2-pyrimidinyl-1-piperazine derivatives, processes for their preparation and medicaments containing them
EP0170213B1 (en) Glutarimide antianxiety and antihypertensive agents
US5143916A (en) Naphthylpiperazines useful as 5-ht1a receptor ligands
JPWO1996007641A1 (ja) 複素環誘導体及び医薬
EP0397040A2 (en) N-heteroaryl-4-quinolinamines, a process for their preparation and their use as medicaments
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
JPH09241161A (ja) 医 薬
EP0238905B1 (en) 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives
US4696927A (en) 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives
FR2558835A1 (fr) Derives d'hydantoine, leur procede de production et medicament les contenant
HU187572B (en) Process for preparing 1,5-diphenyl-pyrazolin-3-one derivatives
EP1484330B1 (en) Triazole compouds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
US4789676A (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives, usefull as anxiolytic agents
EP0236931B1 (en) Aromatic omega-alkylimino-tetrahydro-6H-1,3-Thiazin-6-one derivatives
US4920118A (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3-(2H)one-1,1-dioxide and their use as anxiolytic and anti-hypertensive agents
US6432946B1 (en) 3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligands
US4954500A (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives
US4704389A (en) Aromatic omega-alkyl-imino-tetrahydro-6H-1,3-thiazin-6-one derivatives
US4857526A (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)-one-1,1-dioxide
WO1994011363A1 (fr) Derive de 2-alcoxy-5,6,7,8-tetrahydroquinoxaline, son procede de production, et son utilisation
EP1105388B1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
JPH05345764A (ja) 新規アゼピン誘導体、その製造法およびその用途
JPH06199815A (ja) 2−アルコキシ−5,6,7,8−テトラハイドロキノキサリン誘導体およびその用途

Legal Events

Date Code Title Description
MKLA Lapsed